These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37572408)

  • 61. GC-MS Identification and Quantification of the Synthetic Cannabinoid MDMB-4en- PINACA in Cannabis-derived Material Seized in the Turin Metropolitan Area (Italy).
    Gerace E; Seganti F; Di Corcia D; Vincenti M; Salomone A
    Curr Pharm Des; 2022; 28(32):2618-2621. PubMed ID: 35658890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
    Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
    J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of synthetic cannabinoids in patients with psychotic disorders: case series.
    Celofiga A; Koprivsek J; Klavz J
    J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The identification of synthetic cannabinoids in English prisons.
    Abbott MJ; Dunnett J; Wheeler J; Davidson A
    Forensic Sci Int; 2023 Jul; 348():111613. PubMed ID: 36922254
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
    Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
    Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
    Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
    Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and epidemiological characteristics of patients with acute drug intoxication admitted to ICU.
    Orsini J; Din N; Elahi E; Gomez A; Rajayer S; Malik R; Jean E
    J Community Hosp Intern Med Perspect; 2017 Oct; 7(4):202-207. PubMed ID: 29046744
    [No Abstract]   [Full Text] [Related]  

  • 68. LC-QTOF-MS Presumptive Identification of Synthetic Cannabinoids without Reference Chromatographic Retention/Mass Spectral Information. II. Evaluation of a Computational Approach for Predicting and Identifying Unknown High-Resolution Product Ion Mass Spectra.
    Polettini AE; Kutzler J; Sauer C; Guber S; Schultis W
    J Anal Toxicol; 2021 May; 45(5):440-461. PubMed ID: 32896859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A 4-Year Retrospective Analysis of Patients Presenting at the Emergency Department With Synthetic Cannabinoid Intoxication in Turkey.
    Altintop I
    J Clin Psychopharmacol; 2020; 40(5):464-467. PubMed ID: 32815860
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
    Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2018 Nov; 132(6):1645-1657. PubMed ID: 30219927
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
    Adamowicz P; Meissner E; Maślanka M
    Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
    [No Abstract]   [Full Text] [Related]  

  • 74. A Case of Status Epilepticus and Transient Stress Cardiomyopathy Associated with Smoking the Synthetic Psychoactive Cannabinoid, UR-144.
    Al Fawaz S; Al Deeb M; Huffman JL; Al Kholaif NA; Garlich F; Chuang R
    Am J Case Rep; 2019 Dec; 20():1902-1906. PubMed ID: 31857571
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthetic Cannabinoid Abuse Resulting in ST-Segment Elevation Myocardial Infarction Requiring Percutaneous Coronary Intervention.
    Hamilton RJ; Keyfes V; Banka SS
    J Emerg Med; 2017 Apr; 52(4):496-498. PubMed ID: 27769613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic Cannabinoid Exposure in Adolescents Presenting for Emergency Care.
    Gilley M; Brent J; Calello DP; Wax P; Finkelstein Y;
    Pediatr Emerg Care; 2021 Jan; 37(1):e13-e16. PubMed ID: 29538266
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
    Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
    Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
    Göl E; Çok İ
    Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Types of synthetic cannabinoids seized from illicit trafficking in the territory of the Siberian Federal District (Russia) between 2009-2018.
    Oberenko AV; Kachin SV; Sagalakov SА
    Forensic Sci Int; 2019 Sep; 302():109902. PubMed ID: 31382224
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids.
    Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G
    Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.